FDA Approves First AI to Quantify Coronary Artery Inflammation
EricTopol · x · 2026-07-30
Renowned cardiologist Eric Topol announced that the FDA has approved the first AI tool capable of quantifying coronary artery inflammation (developed by CaristoHeart).
In a linked deep-dive article, he notes this is a major breakthrough in heart disease prevention. Cardiology has been obsessed with fixing blockages for 40 years, but is now experiencing a massive shift towards non-obstructive disease assessment. By analyzing the fat attenuation index around blood vessels, the newly approved AI imaging tool can identify high-risk, vulnerable plaques, potentially leading to a significant reduction in heart attacks.
More from Apps
- Google Launches 24/7 Gemini Agent in India — eternviking · 2026-07-30
- Dev Shares How He Caps AI Product Daily Cost at $500 with Multi-Layer Abuse Prevention — tdhopper · 2026-07-30
- Running Claude Code on Mobile Ends Doomscrolling; PAL Tool Syncs Memory Across Devices — rchardkovacs · 2026-07-30
- Gemini's 24/7 Agent Rolls Out Globally, Supporting Background Execution — Rare_Bunch4348 · 2026-07-30
- GitHub Copilot CLI Adds Multi-Model Cross-Review, Closing 74.7% Performance Gap — 0xkarasy · 2026-07-30
- Carrier Revolt Bundles ChatGPT Go, Offering Up to 12 Months Free — testingcatalog · 2026-07-30